Genetic testing to enhance multiple myeloma treatment
- Details
- Written by Barbara Toman
- Category: News
Rochester, Minnesota - Multiple myeloma is the second most common blood cancer, but most people haven’t heard of it until they or someone they know is diagnosed with the disease. March is Myeloma Action Month - a time to focus attention on the fight against multiple myeloma.
Choosing the right walking shoes to keep you moving
- Details
- Written by Mayo Clinic Staff
- Category: News
Scottsdale, Arizona - Wearing walking shoes that are comfortable and fit your feet can help prevent injuries such as blisters and calluses. A walking shoe should also be fairly lightweight and provide good shock absorption. But not all walking shoes are created equal. Find the fit and features that are right for you.
The American Diabetes Association Urges Americans to Learn Their Diabetes Risk and Take a Minute for their Loved Ones
- Details
- Written by American Diabetes Association
- Category: News
Arlington, Virginia - On Tuesday, March 27, the American Diabetes Association (ADA) asks everyone to take the Type 2 Diabetes Risk Test for themselves or for a loved one to learn their risk for type 2 diabetes for Alert Day. Almost half of all Americans have diabetes or prediabetes, which means if you don’t have diabetes and are not at risk, you probably know someone who is. One in three Americans has prediabetes, a condition where blood glucose levels are higher than normal but not high enough for a type 2 diabetes diagnosis.
U.S. Customs and Border Protection in Miami and Federal Partners Seize Over Six Million Counterfeit Cigarettes
- Details
- Written by IVN
- Category: News
Miami, Florida - U.S. Customs and Border Protection (CBP) officers assigned to the CBP-HSI Mobile Enforcement Team along with U.S. Immigration and Customs Enforcement’s (ICE) Homeland Security Investigations (HSI) commercial fraud agents seized six million counterfeit cigarettes during a recent warehouse inspection. The estimated manufacturer's suggested retail price is $1.1 million.
FDA expands approval of Adcetris for first-line treatment of Stage III or IV classical Hodgkin lymphoma in combination with chemotherapy
- Details
- Written by IVN
- Category: News
Washington, DC - The U.S. Food and Drug Administration approved Adcetris (brentuximab vedotin) to treat adult patients with previously untreated stage III or IV classical Hodgkin lymphoma (cHL) in combination with chemotherapy.
Depression linked to common heart rhythm disorder
- Details
- Written by Darcy Spitz
- Category: News
New Orleans, Louisiana - Depression may increase the risk for atrial fibrillation, the most common heart rhythm disorder that can lead to blood clot formation and stroke, according to preliminary research presented at the American Heart Association’s Epidemiology and Prevention | Lifestyle and Cardiometabolic Health Scientific Sessions 2018, a premier global exchange of the latest advances in population based cardiovascular science for researchers and clinicians.
Page 969 of 3785
- You are here:
-
Home
- News